Zenith Drugs Limited (NSE:ZENITHDRUG)

Zenith Drugs Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,438	1,333	1,316	1,145	916.55	734.02
Other Revenue	-	-	-0	-0	0	0
Revenue	1,438	1,333	1,316	1,145	916.55	734.02
Revenue Growth (YoY)	10.01%	1.29%	14.93%	24.95%	24.87%	-6.22%
Cost of Revenue	953.89	876.42	856.6	783.17	727.11	522.81
Gross Profit	484.59	456.78	459.6	362.02	189.44	211.21
Selling, General & Admin	93.63	79.72	66	52.17	38.44	36.42
Other Operating Expenses	255.23	235.26	213.24	210.8	82.69	104.51
Operating Expenses	401.69	344.65	292.25	276.02	134.39	153.09
Operating Income	82.91	112.13	167.35	86	55.05	58.12
Interest Expense	-34.77	-21.83	-20.01	-11.48	-18.18	-11.46
Interest & Investment Income	19.59	19.59	10.83	1.6	5.22	0.61
Other Non Operating Income (Expenses)	-4.79	-15.28	-9.8	-10.18	-2.93	-1.78
EBT Excluding Unusual Items	62.93	94.61	148.37	65.95	39.17	45.49
Gain (Loss) on Sale of Investments	0.46	0.46	-	-	-	-
Other Unusual Items	-4.62	-2.46	-15.45	-	4.27	0.53
Pretax Income	58.78	92.61	132.92	66.57	44.06	46.02
Income Tax Expense	21	21	37.55	17.76	12.77	15.73
Earnings From Continuing Operations	37.77	71.61	95.37	48.8	31.29	30.29
Minority Interest in Earnings	-	-	-	0	0.1	-
Net Income	37.77	71.61	95.37	48.81	31.38	30.29
Net Income to Common	37.77	71.61	95.37	48.81	31.38	30.29
Net Income Growth	-61.03%	-24.92%	95.40%	55.53%	3.60%	-10.90%
Shares Outstanding (Basic)	17	17	17	12	12	12
Shares Outstanding (Diluted)	17	17	17	12	12	12
Shares Change (YoY)	-70.12%	-	42.91%	-	-	-
EPS (Basic)	2.20	4.18	5.56	4.07	2.62	2.52
EPS (Diluted)	2.20	4.18	5.56	4.07	2.62	2.52
EPS Growth	30.42%	-24.90%	36.70%	55.53%	3.60%	-10.90%
Free Cash Flow	-	-367.74	-211.7	-103.43	-0.89	-6.72
Free Cash Flow Per Share	-	-21.44	-12.35	-8.62	-0.07	-0.56
Dividend Per Share	-	-	0.500	-	-	-
Gross Margin	33.69%	34.26%	34.92%	31.61%	20.67%	28.78%
Operating Margin	5.76%	8.41%	12.71%	7.51%	6.01%	7.92%
Profit Margin	2.63%	5.37%	7.25%	4.26%	3.42%	4.13%
Free Cash Flow Margin	-	-27.58%	-16.08%	-9.03%	-0.10%	-0.92%
EBITDA	136.08	141.8	180.37	99.06	68.31	70.28
EBITDA Margin	9.46%	10.64%	13.70%	8.65%	7.45%	9.57%
D&A For EBITDA	53.17	29.66	13.02	13.05	13.26	12.16
EBIT	82.91	112.13	167.35	86	55.05	58.12
EBIT Margin	5.76%	8.41%	12.71%	7.51%	6.01%	7.92%
Effective Tax Rate	35.73%	22.68%	28.25%	26.68%	28.99%	34.18%
Revenue as Reported	1,475	1,359	1,337	1,158	926.66	735.16
Advertising Expenses	-	4.97	3.8	1.85	1.26	1.84

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.